REGENTIS BIOMATERIALS LTD. - RGNT
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | History | New | 251,510 | 1,695 | 0.6% | — | 1 | +251,510 | New | Q4 2025 | Feb 12, 2026 |
| Warberg Asset Management LLC | History | New | 19,093 | 126 | 0.02% | — | 2 | +19,093 | New | Q4 2025 | Feb 13, 2026 |
| CITADEL ADVISORS LLC | History | New | 10,412 | 70 | 0.0% | — | 3 | +10,412 | New | Q4 2025 | Feb 17, 2026 |